New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Genentech's PD-L1 inhibitor combined with Avastin and chemo improved median progression-free survival by around 20 months ...

FORT MYERS, Fla., Jan. 8, 2026 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) advances gastrointestinal cancer treatment through participation at the global ASCO (R) 2025 ...

Company closed $22M financing to support randomized Phase 2b trial; IND cleared and study initiated; Interim results anticipated in late 2026; topline data expected in H2/2027 ...

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...

The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel ...

New Medicaid eligibility rules may cause more than a million missed cancer screenings, and more than 100 preventable deaths, ...

Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.

Evidence suggests regular exercise can help tackle cancer, and a new study finds that cancer-fighting biological changes can ...

Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...

Metformin, a common type 2 diabetes medication, is being investigated for its potential anti-cancer effects. Research ...

SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...